Anti-idiotypic antibody identifies the structural similarity between the phosphatidylcholine-specific monoclonal antibody and phosphatidylcholine-specific lipid transfer protein  by Nam, Kyung Soo et al.
Volume 269, number 2, 394-397 FEBS 08804 September 1990 
Anti-idiotypic antibody identifies the structural similarity between the 
phosphatidylcholine-specific monoclonal antibody and 
phosphatidylcholine-specific lipid transfer protein 
Kyung Soo Naml, Masato Umedal, Kouji IgarashP and Keizo Inouel 
‘Department of Health Chemistry, Faculty of Pharmaceutical Sciences, The University of Tokyo, 7-3-l Bunkyo-ku, Tokyo 113, Japan 
and 2 Tosoh Corporation, Tokyo Research Center, 2743-l Hayakawa, Ayase-shi, Kanagawa-ken 252, Japan 
Received 13 June 1990 
The polyclonal anti-idiotypic antibody (Anti-Id) has been raised against a monoclonal antibody (mAb) that specifically binds to phosphatidylcho- 
line (PC). The anti-Id bound strongly to PC-specific mAbs, but not to the other mAbs that bind to phosphatidylserine, indicating that the anti-Id 
recognizes the cross-reactive idiotopes expressed on the PC-specific mAbs. The anti-Id also showed an extensive cross-reaction with the PC-specific 
lipid transfer protein isolated from bovine liver and inhibited the lipid transfer activity of the protein. These results trongly suggest that the anti-Id 
recognizes a common structure shared between PC-specific mAbs and the PC-specific lipid transfer protein. 
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1. INTRODUCTION 
Many proteins have been shown to interact specifical- 
ly with choline-containing glycerophospholipids. The 
typical examples are the receptor for platelet activating 
factor [ 11, PC-specific transfer protein [2], PC-specific 
lipid translocater protein that is responsible for the 
transmembrane movement of the lipid [3], I-alkyl-Z 
lyso-sn-glycero-3-phosphocholine:acetyltransferase [4], 
and phospholipase C specific for PC [5]. Although 
much effort has been focused on understanding the 
nature of specific lipid-protein interactions, the dif- 
ficulties of handling these proteins because of their 
limited aqueous solubility and scarcity in the biological 
membranes have hampered the progress in this area. 
The monoclonal antibody that specifically recognizes 
choline-containing lycerophospholipids may not only 
provide valuable information about the lipid-protein in- 
teractions, but may also represent a structural 
temperate for the production of anti-Id that could 
recognize the cross-reactive structures shared between 
the antibody and the actual receptor molecules [a]. In 
the previous study we established a series of mAbs that 
specifically recognizes PC [7]. One of the mAbs, 
designated JE-I , showed a reactivity profile similar, in 
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regard to their head group and acyl chain specificity, 
and effect on the enzyme activities of phospholipases, 
to that of the PC-specific lipid transfer protein [8]. 
Though the primary structure of the PC-specific lipid 
transfer protein has been elucidated [9], the sequence or 
the structure which is responsible for the interaction 
with the substrate has not yet been identified. In the 
present study we produced a cross-reactive anti-Id to a 
PC-specific mAb and investigated the structural 
similarity between the antibody molecule and the PC- 
specific lipid transfer protein. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Egg yolk PC was prepared by chromatography on Aluminum Ox- 
ide Neutral and Iatrobeads. l-acyl-2-[‘4C]linoleoyl-glycerophospho- 
choline and glycerol-tri[9,1O(n)-‘Hloleate was purchased from 
Radiochemical Center, Amersham, UK. 
2.2. Production of anti-Id 
Polyclonal anti-Id to the mAb (JE-1) that specifically binds to PC 
was generated in New Zealand White female rabbits. 3 rabbits were 
immunized with 0.5 mg of JE-1 in complete Freund’s adjuvant sub- 
cutaneously, followed by an injection of the antigen in incomplete 
Freund’s adjuvant 4 weeks later. After the boost, the rabbits were 
bled every week. Immunoglobulin G (IgG) was isolated from the pre- 
immune and immune sera of the rabbits by ammonium sulfate 
precipitation and affinity chromatography on a protein A-Sepharose 
column. The resulting IgG was rendered idiotype specific by two ad- 
sorptions over Sepharose 4B coupled to the isotype and allotype 
matched unrelated mouse monoclonal IgM antibody (kindly provided 
by A. Suzuki, Tokyo Metropolitan Institute of Medical Science). 
2.3. Binding of anti-Id to anti-phospholipid mAbs 
The binding of the anti-Id to anti-phospholipid mAbs was 
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measured by enzyme-linked immunosorbent assay (ELISA) as 
described previously [lo]. Anti-Id bound was detected by biotinylated 
anti-rabbit IgG (ZYMED Laboratories, San Francisco, CA) followed 
by incubation with peroxidase-conjugated streptavidin (ZYMED 
Laboratories). 
2.4. Binding of anti-Id to PC-specific lipid transfer protein 
The PC-specific lipid transfer protein was isolated from bovine 
liver according to the method of Kamp et al. [ 1 l] and was purified to 
homogeneity by gel-filtration column chromatography on TSK 
G2OOOSWXL (Tosoh carp. Tokyo, Japan). The purified protein 
showed a single band with an apparent relative molecular mass of 
25 000 on sodium dodecyl sulfate polyacrylamide gel electrophoresis. 
The binding of the anti-Id to the PC-specific lipid transfer protein was 
examined by ELISA. Briefly, the plates were coated with 14 ng of the 
purified PC-specific lipid transfer protein in 50 ~1 of 0.1 M sodium 
carbonate buffer, pH 9.6, overnight at 4°C. After the wells were 
blocked with PBS containing 30 mg/ml of BSA, a serial dilution of 
anti-Id was added to the well and the mixture was incubated for 2 h 
at room temperature. For the control, IgG purified from the pre- 
immune serum was used instead of anti-Id. The anti-Id bound was 
determined as described in 2.3. 
2.5. Inhibition of the binding of anti-phospholipid mAbs by anti-Id 
The binding of the anti-phospholipid mAbs to the corresponding 
phospholipid antigens was determined by ELISA as described 
previously [12]. The inhibition of binding of the anti-phospholipid 
mAbs by anti-Id was examined as follows. Anti-phospholipid mAbs 
were preincubated with serial dilutions of anti-Id for 2 h at room 
temperature. The mixtures were transferred to microtiter wells coated 
with phospholipid antigens and were incubated for 2 h at room 
temperature. The anti-phospholipid mAbs bound to the correspon- 
ding phospholipid antigens were determined by biotinylated anti- 
mouse Igs (ZYMED Laboratories) followed by incubation with 
alkaline phosphatase-conjugated streptavidin (ZYMED Labora- 
tories). 
2.6. Inhibition of the lipid tramfer activity by anti-Id 
The transfer of PC from liposomes to mitochondria was examined 
according to the method of Bloj and Zilversmit [13]. Briefly, 
liposomes composed of egg yolk phosphatidylcholine and bis[hex- 
adecanoyllphosphate with a trace amount of I-acyl-2-[“C]linoleoyl- 
glycerophosphocholine and glycerol tri[9,10(n)-3H]oleate asa ‘non- 
exchangeable marker’ were used for the assay. Mitochondria were 
prepared from male albino rats (350 g) of the Wistar strain. A given 
amount of liposomes (12.5 nmol phospholipid phosphorus) was in- 
cubated with mitochondria (250 pg as protein) in the presence or 
absence of the partially purified PC-specific lipid transfer protein in 
0.5 ml of 50 mM Tris/HCI buffer pH 7.4 containing 0.25 M sucrose 
and 1 mM EDTA. After incubation for 50 min at 37OC, the mitochon- 
dria were precipitated by centrifugation at 15 000 x g for 15 min at 
4”C, and the supernatants were counted in a Packard liquid scintilla- 
tion counter (model 3320). The percentage transfer of 
1-acy1-2-[“C]lino1eoy1-g1ycerophosphocho1ine from liposome to 
mitochondria was calculated from the formula as described previous- 
ly [14]. In the inhibition assay, the PC-specific transfer protein was 
first mixed with various amounts of anti-Id or IgG from the pre- 
immune serum, and then liposome (12.5 nmol as phospholipid 
phosphorus) and mitochondria (250 r(8 as protein) were added to the 
mixture. The resulting mixtures were incubated for 50 min at 37’C 
and the percentage transfer of PC was determined as described above. 
3. RESULTS AND DISCUSSIONS 
3.1. Specificity of anti-Id 
Polyclonal anti-Id was produced by immunizing rab- 
bits with PC-specific mAb, JE-1. Among 3 rabbits im- 
munized with JE-1, one rabbit with the highest anti-Id 
titer was selected and anti-Id was prepared from the 
serum. The specificity of the anti-Id was examined by 
ELISA. The anti-Id bound strongly to JE-1 and to 
another PC-specific mAb, JE-8, but not to anti-PS 
mAbs (PS4A7 and PS3A), nor to anti-phosphoryl- 
choline mAb TEPC 15 (Fig. 1). No appreciable binding 
of the IgG purified from the pre-immune serum was 
observed in any of the mAbs examined (data not 
shown). The reactivities of mAbs that recognize 
phosphorycholine have been extensively studied 
[15-171. Although these mAbs have been shown to 
recognize a negatively charged phosphate and the 
trimethyl structure of the choline residue [17], our 
previous analysis [7] indicated that the anti-PC mAbs 
had reactivity profiles distinct from those of anti- 
phosphorylcholine mAbs. The fact that the anti-Id rais- 
ed in this study could not cross-react with the anti- 
phosphorylcholine mAb (TEPC 15) indicates that the 
anti-PC mAbs may belong to a distinct family of the 
anti-phospholipid antibodies and the anti-Id may 
recognize some unique structure expressed on the anti- 
PC mAbs. To determine whether the anti-Id reacted 
with the combining site related idiotopes, the inhibition 
of the binding of anti-phospholipid antibodies to 
phospholipid antigens was examined. The anti-Id total- 
ly inhibited the binding of JE-1 to PC and partially in- 
hibited the binding of JE-8. The anti-Id had no effect 
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Fig. 1. Detection of idiotypic determinants on anti-phospholipid 
mAb. Microtiter plates were coated with anti-PC (0. JE-1: 0, JE-8), 
anti-PS ( q , PS4A7: n , PS3A) mAbs and TEPC 15 (A). The anti-Id 
bound was detected with biotinylated anti-rabbit IgG and peroxidase- 
conjugated streptavidin. 
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2). The result suggests that the anti-Id recognizes 
idiotypes that are identical or spatially in proximity to 
the combining sites of the anti-PC mAbs. 
3.2. The anti-Id cross-reacts with PC-specific lipid 
transfer protein 
Since the reactivity profile of JE-1 showed a close 
similarity to that of the PC-specific lipid transfer pro- 
tein [7,8], the cross-reactivity of the anti-Id with the 
PC-specific lipid transfer protein purified from bovine 
liver was examined. As shown in Fig. 3, the anti-Id did 
bind to the transfer protein, but the control IgG from 
the pre-immune serum did not (Fig. 3). The binding of 
the anti-Id to the PC-specific lipid transfer protein was 
inhibited by both JE-1 and JE-g, but not by anti-PS 
mAb, PS4A7 (Fig. 4). This observation further con- 
firms that the anti-Id recognizes the cross-reactive 
determinants expressed on both the anti-PC mAbs and 
the PC-specific lipid transfer protein. Finally, we ex- 
amined whether the anti-Id inhibits the lipid transfer ac- 
tivity of the PC-specific lipid transfer protein (Fig. 5). 
The partially purified PC-specific lipid transfer protein 
(about 3 kg) which is capable of transferring 25% of 
phosphatidylcholine molecules between the vesicles and 
mitochondria in the present assay system was selected 
for the inhibition analysis. The anti-Id inhibited the 
transfer activity of the PC-specific lipid transfer protein 
in a dose dependent manner, whereas the IgG purified 
from pre-immune sera did not inhibit the transfer. Re- 
cent findings showed that anti-Id could recognize cross- 
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Fig. 2. Inhibition of the binding of the anti-PC mAbs by anti-Id. 
Anti-PC (a, J&l: 0, JE-8) andanti-PS (0, PS4A7: (w), PS3A) mAbs 
were preincubated with various amounts of anti-Id. and the mixture 
was transferred to microtiter wells coated with the corresponding 
phospholipid antigens. The results are expressed as percentage 
inhibition of the binding measured in the absence of anti-Id. 
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Fig. 3. Binding of anti-Id to the PC-specific lipid transfer protein. 
Microtiter plates were coated with the purified PC-specific lipid 
transfer protein and were incubated with various amounts of anti-Id 
IgG (0) or IgG from pre-immune serum ( A ). The anti-Id bound was 
detected with biotinylated anti-rabbit IgG and peroxidase-conjugated 
streptavidin. 
receptor molecules, and some of the anti-Id carry the in- 
ternal image properties of the ligand molecule 
[6,18-201. In these studies extremely high concentra- 
tions of anti-Id were required to compete with the 
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Fig. 4. Inhibition of the binding anti-Id to the PC-specific lipid 
transfer protein by anti-PC mAbs. Anti-Id was preincubated with 
various amounts of anti-PC (a, JE-1: 0, JE-8) and anti-PS ( q , 
PS4A7) mAb. The mixtures were transferred to microtiter wells 
coated with the PC-specific lipid transfer protein. Anti-Id bound was 
detected by biotinylated anti-rabbit IgG and alkaline phosphatase- 
conjugated streptavidin. 
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Fig. 5. Inhibition of the transfer activity of the PC-specific lipid 
transfer protein by anti-Id. Liposomes (12.5 nmol phospholipid 
phosphorus) and mitichondria (250 r(8 protein) were incubated with 
partially purified PC-specific lipid transfer protein in the presence of 
anti-Id IgG (*) or IgG from pre-immune serum (0). The results are 
expressed as percentage+ibition of the transfer activity measured in 
the absence of the antibody, and all values are the mean f SD of 4 
different experiments. 
ligand molecules. In the present study the highest con- 
centration of the anti-Id exhibited a mean of 23% in- 
hibition of the transfer activity. Since we obtained ex- 
tremely small amounts of IgG when the anti-Id was fur- 
ther purified by an affinity chromatography on JE-1 
coupled to Sepharose (data not shown), the content of 
the anti-Id that carries the internal image properties of 
PC molecule may be too low to fully compete with the 
PC molecules for the binding to the PC-specific lipid 
transfer protein. 
The present study revealed that the anti-PC mAbs 
and the PC-specific lipid transfer protein share the 
common structure that was identified by the anti-Id 
against anti-PC mAb, and some of the anti-Id may 
carry the internal image property of PC molecule. We 
hope that the anti-Id will provide useful tools for the 
identification and purification of a family of choline- 
containing glycerophospholipid binding proteins that 
have not been purified by the conventional procedures 
of the protein purification. 
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